AI assistant
Sending…
Riot Platforms, Inc. — Director's Dealing 2012
Dec 13, 2012
30793_dirs_2012-12-13_5bd79e78-7898-4bb5-b5ba-1a0079207f09.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-12-11
Reporting Person: Lundy Steve (Director, CEO and President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-11 | Stock Option (Right to Buy) | $2.10 | A | 99336 | Acquired | 2012-12-11 | Common Stock (99336) | Direct |
Footnotes
F1: The option to purchase 99,336 shares of common stock shall become exercisable in full on December 11, 2013.
More from Riot Platforms, Inc.
Annual Report
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Feb 4
Regulatory Filings
2026
Jan 16
Board/Management Information
2026
Jan 5